PlainRecalls
FDA Drug Moderate Class II Terminated

Ephedrine Sulfate Injection, USP, 50 mg/mL, Single Dose Vial, packaged in a) 1 mL fill in a 2 mL Vial (NDC: 69053-008-01); and b) 25 x 2 mL Vials (NDC 69053-008-02), Rx only, Manufactured for: Andersen Pharmaceutical, White Plains, NY 10605.

Reported: September 14, 2016 Initiated: August 10, 2016 #D-1498-2016

Product Description

Ephedrine Sulfate Injection, USP, 50 mg/mL, Single Dose Vial, packaged in a) 1 mL fill in a 2 mL Vial (NDC: 69053-008-01); and b) 25 x 2 mL Vials (NDC 69053-008-02), Rx only, Manufactured for: Andersen Pharmaceutical, White Plains, NY 10605.

Reason for Recall

Lack of Assurance of Sterility: An FDA inspection at the facility raised concerns that product sterility was potentially impacted.

Details

Units Affected
1,928,075 vials
Distribution
Nationwide
Location
Oklahoma City, OK

Frequently Asked Questions

What product was recalled?
Ephedrine Sulfate Injection, USP, 50 mg/mL, Single Dose Vial, packaged in a) 1 mL fill in a 2 mL Vial (NDC: 69053-008-01); and b) 25 x 2 mL Vials (NDC 69053-008-02), Rx only, Manufactured for: Andersen Pharmaceutical, White Plains, NY 10605.. Recalled by Allergy Laboratories, Inc.. Units affected: 1,928,075 vials.
Why was this product recalled?
Lack of Assurance of Sterility: An FDA inspection at the facility raised concerns that product sterility was potentially impacted.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 14, 2016. Severity: Moderate. Recall number: D-1498-2016.